Hepalink Pharma's Thrombosis Medication Gets South African Marketing Approval

MT Newswires Live

2025/04/25

South African authorities approved Shenzhen Hepalink Pharmaceutical's (HKG:9989, SHE:002399) sale of its ivenoxin injection, according to a Thursday filing with the Hong Kong bourse.

Ivenoxin is indicated to prevent thrombosis before and after surgery. It also helps with reducing thrombosis risk in patients with acute conditions causing movement restrictions and in hemodialysis patients.

The drug also treats deep vein thrombosis and reduces complications in unstable angina, the filing stated.

Subsidiary Shenzhen Techdow Medicine produces the injection.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2530433079"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2530433079\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2530433079?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-25 10:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2530433079","market":"hk","top_or_hot":-1,"title":"Hepalink Pharma's Thrombosis Medication Gets South African Marketing Approval","media":"MT Newswires Live","content":"<html><body><p> South African authorities approved Shenzhen Hepalink Pharmaceutical's (HKG:9989, SHE:002399) sale of its ivenoxin injection, according to a Thursday filing with the Hong Kong bourse.</p><p>Ivenoxin is indicated to prevent thrombosis before and after surgery. It also helps with reducing thrombosis risk in patients with acute conditions causing movement restrictions and in hemodialysis patients.</p><p>The drug also treats deep vein thrombosis and reduces complications in unstable angina, the filing stated.</p><p>Subsidiary Shenzhen Techdow Medicine produces the injection.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hepalink Pharma's Thrombosis Medication Gets South African Marketing Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHepalink Pharma's Thrombosis Medication Gets South African Marketing Approval\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-04-25 10:18</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> South African authorities approved Shenzhen Hepalink Pharmaceutical's (HKG:9989, SHE:002399) sale of its ivenoxin injection, according to a Thursday filing with the Hong Kong bourse.</p><p>Ivenoxin is indicated to prevent thrombosis before and after surgery. It also helps with reducing thrombosis risk in patients with acute conditions causing movement restrictions and in hemodialysis patients.</p><p>The drug also treats deep vein thrombosis and reduces complications in unstable angina, the filing stated.</p><p>Subsidiary Shenzhen Techdow Medicine produces the injection.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1191","symbol_name":"製藥","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2530433079","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2530433079","pubTimestamp":1745547489,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"South African authorities approved Shenzhen Hepalink Pharmaceutical's  sale of its ivenoxin injection, according to a Thursday filing with the Hong Kong bourse.Ivenoxin is indicated to prevent thrombosis before and after surgery. It also helps with reducing thrombosis risk in patients with acute conditions causing movement restrictions and in hemodialysis patients.The drug also treats deep vein thrombosis and reduces complications in unstable angina, the filing stated.Subsidiary Shenzhen Techdow Medicine produces the injection.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1191":"制药","BK0188":"融资融券","BK0070":"员工持股","09989":"海普瑞","BK0239":"医药制造","002399":"海普瑞"},"translate_title":"海普瑞制药血栓药物获南非上市批准","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09989":1,"002399":0.9},"content_text":"South African authorities approved Shenzhen Hepalink Pharmaceutical's (HKG:9989, SHE:002399) sale of its ivenoxin injection, according to a Thursday filing with the Hong Kong bourse.Ivenoxin is indicated to prevent thrombosis before and after surgery. It also helps with reducing thrombosis risk in patients with acute conditions causing movement restrictions and in hemodialysis patients.The drug also treats deep vein thrombosis and reduces complications in unstable angina, the filing stated.Subsidiary Shenzhen Techdow Medicine produces the injection.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}